Received Jun 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPAB | HEP A + HEP B (TWINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | P2443 | IM / RA |
| PNC20 | PNEUMO (PREVNAR20) | PFIZER\WYETH | N/A | LN4927 | IM / RA |
Patient received a 2nd dose of Prevnar 20 on 6/24/2025 despite receiving a dose of the same on 2/3/2023. This 2nd dose was determined to be clinically inappropriate as current guidelines indicate patient should receive only one dose of Prevnar 20.